《大行》里昂料京东健康(06618.HK 药品销售或持续带来正面惊喜 但目标价降至66.5元

阿斯达克财经
Mar 06

里昂研究报告指出,京东健康(06618.HK) 公布截至去年12月底止全年业绩, 其中去年下半年表现胜预期,营收年增28%至382亿元人民币(下同),调整后息税前利润年增88%至19亿元。里昂预计集团营收动能将持续,在药品(特别是原研处方药)的带动下,2026年营收将年增18%;并预计广告收入应能实现20%的年增长;因增加对即时零售(O2O)、线下药房和人工智能的投资,以及利息收入减少,调整后...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10